Advertisements


We are Sorry, This Page doesn't Exist


Momenta announces presentation on potential for anti-FcRn therapeutics

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 17th, 2018

Evelo Announces Potential Pricing for IPO

Evelo Biosciences expects to price its more than 5 million shares in a range that results in an initial public offering valued up to almost $104 million......»»

Category: blogSource: 247wallstApr 30th, 2018

Unity Biotech Announces Potential Pricing for IPO

Unity Biotechnology plans to offer 5 million shares in an initial public offering valued up to more than $103 million......»»

Category: blogSource: 247wallstApr 24th, 2018

Smartsheet Announces Potential Pricing for IPO

Smartsheet intends to price more than 11 million shares in a range that results in an initial public offering valued up to more than $160 million......»»

Category: blogSource: 247wallstApr 16th, 2018

First Caribbean International Bank Announces Potential Pricing for IPO

First Caribbean International Bank expects to price its more than 9 million shares for an initial public offering valued up to $276 million......»»

Category: blogSource: 247wallstApr 11th, 2018

Surface Oncology Announces Potential Pricing for IPO

Surface Oncology intends to price 6 million shares to result in an initial public offering valued up to more than $103 million......»»

Category: blogSource: 247wallstApr 9th, 2018

Menlo Therapeutics announces results from Phase 2 trial of Serlopitant

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 8th, 2018

Voyager Therapeutics announces FDA RMAT designation granted for VY-AADC

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewall5 hr. 17 min. ago

Trillium Therapeutics announces "at-the-market" issuance program

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 19th, 2018

Prothena announces trial data for potential Parkinson"s treatment

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 19th, 2018

Anika Therapeutics announces strong patient response in CINGAL 16-02 trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 19th, 2018

Renren Announces Unaudited First Quarter 2018 Financial Results and Update on Potential Financial Impact of the Transaction Announced on April 30, 2018

Renren Announces Unaudited First Quarter 2018 Financial Results and Update on Potential Financial Impact of the Transaction Announced on April 30, 2018 PR Newswire BEIJING, June 19, 2018 BEIJI.....»»

Category: earningsSource: benzingaJun 19th, 2018

Protagonist Therapeutics announces results from Phase 1 study of PTG-300

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 18th, 2018

Global Blood Therapeutics announces new Phase 2a voxelotor data

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 15th, 2018

Alexandria (ARE) Announces Pricing of $900M Senior Notes

Zacks.....»»

Category: topSource: redinewsJun 13th, 2018

Alexandria (ARE) Announces Pricing of $900M Senior Notes

Alexandria (ARE) .....»»

Category: smallbizSource: nytJun 13th, 2018

Aclaris Therapeutics announces publication of two pivotal trials of ESKATA

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 12th, 2018

Sage Therapeutics announces pivotal Phase 3 trial for SAGE-217

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 12th, 2018

CRISPR Crashes After Study Highlights Potential Cancer Risk From Gene-Editing

Don't mess with mother nature.. or crowded longs! Crispr Therapeutics led gene-editing stocks lower after new studies published by Nature Medicine found that cells whose genomes are edited with the CRISPR-Cas9 technology have the po.....»»

Category: blogSource: zerohedgeJun 11th, 2018

VBL Therapeutics announces knockout of MOSPD2 can reduce metastasis by up to 95%

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 5th, 2018